Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Flaherty

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Journal of the American College of Cardiology|January 17, 2009
Acute heart failure syndromes in patients with coronary artery disease early assessment and treatmentJames D Flaherty, Jeroen J Bax, Leonardo De Luca, et al.
Circulation|December 10, 2003
Antirestenotic effects of a locally delivered caspase inhibitor in a balloon injury modelNirat Beohar, James D Flaherty, Charles J Davidson, et al.
JACC. Asia|June 16, 2023
Race-Specific Impact of Conventional Surgical Risk Score on 1-Year Mortality After Transcatheter Aortic Valve ReplacementHoyun Kim, Do-Yoon Kang, Jung-Min Ahn, et al.
JACC. Asia|April 25, 2024
Sex-Specific Disparities in Clinical Outcomes After Transcatheter Aortic Valve Replacement Among Different Racial PopulationsMijin Kim, Do-Yoon Kang, Jung-Min Ahn, et al.
Heart (British Cardiac Society)|February 3, 2022
Inter-racial differences in patients undergoing transcatheter aortic valve implantationDo-Yoon Kang, Jung-Min Ahn, Juyong Brian Kim, et al.
JACC. Cardiovascular Interventions|November 28, 2021
Racial Differences in the Incidence and Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve ReplacementHanbit Park, Jung-Min Ahn, Do-Yoon Kang, et al.
JACC. Heart Failure|June 27, 2024
2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF IIFinn Gustafsson, Mark C Petrie, Jan Komtebedde, et al.
The American Journal of Cardiology|December 13, 2022
Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary InterventionJudit Karacsonyi, Karen Deffenbacher, Keith H Benzuly, et al.
Circulation. Population Health and Outcomes|January 19, 2026
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF IIAndrew A Girard, Uma Mylavarapu, Jan Komtebedde, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 4, 2025
Obstructive sleep apnea syndrome in chronic total occlusion percutaneous coronary intervention; insights from the PROGRESS-CTO registryOzgur Selim Ser, Deniz Mutlu, Michaella Alexandrou, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Journal of the American College of Cardiology|January 17, 2009
Acute heart failure syndromes in patients with coronary artery disease early assessment and treatmentJames D Flaherty, Jeroen J Bax, Leonardo De Luca, et al.
Circulation|December 10, 2003
Antirestenotic effects of a locally delivered caspase inhibitor in a balloon injury modelNirat Beohar, James D Flaherty, Charles J Davidson, et al.
JACC. Asia|June 16, 2023
Race-Specific Impact of Conventional Surgical Risk Score on 1-Year Mortality After Transcatheter Aortic Valve ReplacementHoyun Kim, Do-Yoon Kang, Jung-Min Ahn, et al.
JACC. Asia|April 25, 2024
Sex-Specific Disparities in Clinical Outcomes After Transcatheter Aortic Valve Replacement Among Different Racial PopulationsMijin Kim, Do-Yoon Kang, Jung-Min Ahn, et al.
Heart (British Cardiac Society)|February 3, 2022
Inter-racial differences in patients undergoing transcatheter aortic valve implantationDo-Yoon Kang, Jung-Min Ahn, Juyong Brian Kim, et al.
JACC. Cardiovascular Interventions|November 28, 2021
Racial Differences in the Incidence and Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve ReplacementHanbit Park, Jung-Min Ahn, Do-Yoon Kang, et al.
JACC. Heart Failure|June 27, 2024
2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF IIFinn Gustafsson, Mark C Petrie, Jan Komtebedde, et al.
The American Journal of Cardiology|December 13, 2022
Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary InterventionJudit Karacsonyi, Karen Deffenbacher, Keith H Benzuly, et al.
Circulation. Population Health and Outcomes|January 19, 2026
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF IIAndrew A Girard, Uma Mylavarapu, Jan Komtebedde, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|April 4, 2025
Obstructive sleep apnea syndrome in chronic total occlusion percutaneous coronary intervention; insights from the PROGRESS-CTO registryOzgur Selim Ser, Deniz Mutlu, Michaella Alexandrou, et al.
Pageof 10